Read More 1 minute read Analyst Ratings Downgrades News Price Target Rosenblatt Downgrades Snap to Neutral, Lowers Price Target to $14 By Benzinga Newsdesk July 22, 6:58 AM Rosenblatt analyst Barton Crockett downgrades Snap (NYSE:SNAP) from Buy to Neutral and lowers the price target from $23 to $14. SNAP
Read More 1 minute read Analyst Ratings Downgrades News Price Target Piper Sandler Downgrades Continental Resources to Underweight, Lowers Price Target to $70 By Benzinga Newsdesk July 22, 6:19 AM Piper Sandler analyst Mark Lear downgrades Continental Resources (NYSE:CLR) from Neutral to Underweight and lowers the price target from $76 to $70. CLR
Read More 1 minute read Analyst Ratings Downgrades News Oppenheimer Downgrades Snap to Perform By Benzinga Newsdesk July 22, 6:16 AM Oppenheimer analyst Jason Helfstein downgrades Snap (NYSE:SNAP) from Outperform to Perform. SNAP
Read More 1 minute read Analyst Ratings Downgrades News Price Target Stifel Downgrades Snap to Hold, Lowers Price Target to $14 By Benzinga Newsdesk July 22, 6:14 AM Stifel analyst Mark Kelley downgrades Snap (NYSE:SNAP) from Buy to Hold and lowers the price target from $20 to $14. SNAP
Read More 1 minute read Analyst Ratings Downgrades News Price Target Goldman Sachs Downgrades Snap to Neutral, Lowers Price Target to $12 By Benzinga Newsdesk July 22, 6:12 AM Goldman Sachs analyst Eric Sheridan downgrades Snap (NYSE:SNAP) from Buy to Neutral and lowers the price target from $25 to $12. SNAP
Read More 1 minute read Analyst Ratings Downgrades News Keybanc Downgrades Snap to Sector Weight By Benzinga Newsdesk July 22, 5:08 AM Keybanc analyst Justin Patterson downgrades Snap (NYSE:SNAP) from Overweight to Sector Weight. SNAP
Read More 1 minute read Analyst Ratings Downgrades News Price Target Truist Securities Downgrades Snap to Hold, Announces $12 Price Target By Benzinga Newsdesk July 22, 4:57 AM Truist Securities analyst Youssef Squali downgrades Snap (NYSE:SNAP) from Buy to Hold and announces $12 price target. SNAP
Read More 1 minute read Analyst Ratings Downgrades News Price Target Jefferies Downgrades Aveanna Healthcare Hldgs to Hold, Lowers Price Target to $2.5 By Benzinga Newsdesk July 22, 4:47 AM Jefferies analyst Brian Tanquilut downgrades Aveanna Healthcare Hldgs (NASDAQ:AVAH) from Buy to Hold and lowers the price target from $9 to $2.5. AVAH
Read More 1 minute read Analyst Ratings Downgrades News Price Target Jefferies Downgrades Apartment Income REIT to Hold, Lowers Price Target to $44 By Benzinga Newsdesk July 22, 4:41 AM Jefferies analyst Jonathan Petersen downgrades Apartment Income REIT (NYSE:AIRC) from Buy to Hold and lowers the price target from $47 to $44. AIRC
Read More 1 minute read Analyst Color Analyst Ratings Downgrades General Health Care News Penny Stocks Small Cap This Analyst Says Invitae’s Current Valuation ‘Not Accommodative’ By Vandana Singh July 21, 3:28 PM Raymond James has downgraded Invitae Corp (NYSE:NVTA) to Market Perform from Outperform following news of a full reset, including leadership changes… NVTA